Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
8,516
-557
-6% -$92.8K 0.01% 446
2026
Q1
$1.9M Buy
9,073
+782
+9% +$197K 0.01% 370
2025
Q4
$2.36M Sell
8,291
-9,009
-52% -$2.82M 0.01% 370
2025
Q3
$5.34M Buy
17,300
+8,123
+89% +$2.55M 0.03% 265
2025
Q2
$2.88M Sell
9,177
-26,251
-74% -$7.58M 0.02% 309
2025
Q1
$9.3M Buy
35,428
+33,298
+1,563% +$9.01M 0.06% 174
2024
Q4
$556K Buy
+2,130
New +$536K ﹤0.01% 540
2024
Q3
Sell
-34,725
Closed -$7.01M 590
2024
Q2
$7.01M Sell
34,725
-144
-0.4% -$25.9K 0.04% 275
2024
Q1
$5.98M Sell
34,869
-19,131
-35% -$3.57M 0.04% 298
2023
Q4
$11.7M Buy
54,000
+45,235
+516% +$7.76M 0.09% 193
2023
Q3
$1.4M Buy
+8,765
New +$1.96M 0.01% 416
2023
Q2
Sell
-1
Closed -$319 653
2023
Q1
$319 Buy
+1
New +$296 ﹤0.01% 652

Other funds holding PODD

ING Group's PODD Position: Q2 2026 in Review

ING Group reduced its Insulet (PODD) stake by 6.1% in Q2 2026, selling an estimated $92.8K and leaving 8,516 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #446.

ING Group first reported a position in PODD in Q1 2023 and has held it in 12 quarters since. The position peaked at $11.7M in Q4 2023. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • ING Group held 8,516 shares of Insulet worth $1.3M as of Q2 2026.
  • ING Group sold 557 Insulet shares in Q2 2026, an estimated $92.8K.
  • Insulet made up 0.01% of ING Group's portfolio in Q2 2026, its #446 holding.
  • ING Group first reported a position in Insulet in Q1 2023 and has held it in 12 quarters since.
  • ING Group's Insulet position peaked at $11.7M in Q4 2023.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.